GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:890202) » Definitions » EV-to-FCF

Solara Active Pharma Sciences (BOM:890202) EV-to-FCF : (As of Dec. 14, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Solara Active Pharma Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Solara Active Pharma Sciences's Enterprise Value is ₹40,551 Mil. Solara Active Pharma Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0 Mil. Therefore, Solara Active Pharma Sciences's EV-to-FCF for today is .

The historical rank and industry rank for Solara Active Pharma Sciences's EV-to-FCF or its related term are showing as below:

BOM:890202' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 66.67
Current: 63.01

During the past 8 years, the highest EV-to-FCF of Solara Active Pharma Sciences was 66.67. The lowest was 0.00. And the median was 0.00.

BOM:890202's EV-to-FCF is ranked worse than
77.68% of 551 companies
in the Drug Manufacturers industry
Industry Median: 25.85 vs BOM:890202: 63.01

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Solara Active Pharma Sciences's stock price is ₹465.50. Solara Active Pharma Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹-136.828. Therefore, Solara Active Pharma Sciences's PE Ratio (TTM) for today is At Loss.


Solara Active Pharma Sciences EV-to-FCF Historical Data

The historical data trend for Solara Active Pharma Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences EV-to-FCF Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial -69.62 -285.85 -7.52 48.70 34.60

Solara Active Pharma Sciences Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 34.60 - -

Competitive Comparison of Solara Active Pharma Sciences's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's EV-to-FCF falls into.



Solara Active Pharma Sciences EV-to-FCF Calculation

Solara Active Pharma Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=40551.078/0
=

Solara Active Pharma Sciences's current Enterprise Value is ₹40,551 Mil.
Solara Active Pharma Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solara Active Pharma Sciences  (BOM:890202) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Solara Active Pharma Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=465.50/-136.828
=At Loss

Solara Active Pharma Sciences's share price for today is ₹465.50.
Solara Active Pharma Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-136.828.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Solara Active Pharma Sciences EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences Business Description

Comparable Companies
Traded in Other Exchanges
Address
27, Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences Headlines

No Headlines